Wearable tech aims to boost exercise and quality of life in cancer patients

NCT ID NCT06855706

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a personalized physical activity program using a wearable device (like a Fitbit) can help people with ovarian or endometrial cancer exercise more and improve their quality of life. About 120 participants will either receive tailored activity goals and feedback or standard exercise advice. The study also looks at how exercise affects the immune system and gut bacteria.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
personalized physical activity intervention via wearable device
What this could lead to
If successful, this could show that tailored activity goals help cancer patients exercise more and feel better, potentially improving immune function and daily life.
What could go wrong
This is a small, early-stage trial (120 participants) focused on feasibility and short-term outcomes. Results may not apply to all patients, and the intervention may not lead to lasting changes or clinical benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Roswell Park Cancer Institute

    RECRUITING

    Buffalo, New York, 14263, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.